• 最近访问:
发表于 2026-03-31 18:20:21 股吧网页版
健康元:健康元药业集团股份有限公司2025年年度报告(英文版) 查看PDF原文

公告日期:2026-04-01



Important Notice

I. The Board of Directors (the “Board”), directors and senior management of the Company
hereby warrant the truthfulness, accuracy and completeness of the contents of this annual
report (the “Report”), and that there are no false representations, misleading statements or
material omissions contained in the Report, and severally and jointly accept legal
responsibility.

II. All directors of the Company attended the Board meeting.

III. Grant Thornton issued a standard unqualified audit report for the Company.

IV. Mr. Zhu Baoguo (朱保国), the person-in-charge of the Company, and Mr. Qiu Qingfeng
(邱庆丰),theperson-in-charge ofaccountingwork, and Ms.GuoChenlu (郭琛璐), theperson-
in-charge of the accounting department (the head of the accounting department) declare that
they hereby warrant the truthfulness, accuracy and completeness of the financial statements
contained in the Report.

V. Profit distribution plan or plan for conversion of capital reserve to share capital approved
by the Board resolution during the Reporting Period

Based on the audit conducted by Grant Thornton, as of 31 December 2025, the undistributed profit
in the parent company statement of the Company amounted to RMB2,775.7845 million. Pursuant
to the resolution of the Company's Board of Directors, the Company plans to distribute cash
dividends for the fiscal year 2025, based on the Company’s total share capital on the record date to
be determined upon implementation of the 2025 profit distribution plan. The Company plans to
distribute a cash dividend of RMB2.20 (tax inclusive) for every 10 shares to all shareholders of the
Company, and the remaining undistributed profits will be carried forward to the following year.
As of the end of the Reporting Period, details regarding the accumulated losses not yet offset
of the parent company and their impact on matters such as dividend distribution.

□Applicable √N/A

VI. Risk warning for forward-looking statements

√Ap……
[点击查看PDF原文]

提示:本网不保证其真实性和客观性,一切有关该股的有效信息,以交易所的公告为准,敬请投资者注意风险。

郑重声明:用户在财富号/股吧/博客等社区发表的所有信息(包括但不限于文字、视频、音频、数据及图表)仅代表个人观点,与本网站立场无关,不对您构成任何投资建议,据此操作风险自担。请勿相信代客理财、免费荐股和炒股培训等宣传内容,远离非法证券活动。请勿添加发言用户的手机号码、公众号、微博、微信及QQ等信息,谨防上当受骗!
作者:您目前是匿名发表   登录 | 5秒注册 作者:,欢迎留言 退出发表新主题
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-61278686 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:4000300059/952500